tiprankstipranks
Xtant Medical Holdings Inc (XTNT)
XASE:XTNT
US Market
XTNT
Xtant Medical Holdings
RESEARCH TOOLSreports
Want to see XTNT full AI Analyst Report?

Xtant Medical Holdings (XTNT) Ratios

294 Followers

Xtant Medical Holdings Ratios

XTNT's free cash flow for Q4 2025 was $0.55. For the 2025 fiscal year, XTNT's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 2.65 2.65 2.35 2.82 3.24
Quick Ratio
 1.63 1.63 1.00 1.22 2.10
Cash Ratio
 0.58 0.58 0.22 0.25 1.33
Solvency Ratio
 0.24 0.24 -0.24 0.09 -0.28
Operating Cash Flow Ratio
 0.43 0.43 -0.42 -0.41 -0.35
Short-Term Operating Cash Flow Coverage
 0.87 0.87 -0.98 -2.06 -0.94
Net Current Asset Value
$ 35.05M$ 35.05M$ 16.24M$ 23.61M$ 23.26M
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.31 0.37 0.25 0.28
Debt-to-Equity Ratio
 0.56 0.56 0.82 0.46 0.50
Debt-to-Capital Ratio
 0.36 0.36 0.45 0.31 0.33
Long-Term Debt-to-Capital Ratio
 0.18 0.18 0.34 0.25 0.22
Financial Leverage Ratio
 1.85 1.85 2.18 1.80 1.76
Debt Service Coverage Ratio
 0.77 0.77 -0.50 0.90 -0.74
Interest Coverage Ratio
 1.98 1.98 -2.90 -3.46 -3.99
Debt to Market Cap
 0.35 0.23 0.58 0.16 0.25
Interest Debt Per Share
 0.23 0.23 0.29 0.22 0.20
Net Debt to EBITDA
 0.73 0.73 -3.67 3.52 0.59
Profitability Margins
Gross Profit Margin
62.92%62.92%58.17%60.75%55.44%
EBIT Margin
7.97%7.97%-10.32%2.08%-11.60%
EBITDA Margin
11.87%11.87%-6.72%5.56%-9.36%
Operating Profit Margin
5.44%5.44%-10.30%-11.13%-11.65%
Pretax Profit Margin
5.23%5.23%-13.87%-1.14%-14.52%
Net Profit Margin
3.71%3.71%-14.03%0.72%-14.64%
Continuous Operations Profit Margin
3.71%3.71%-14.03%0.72%-14.64%
Net Income Per EBT
71.03%71.03%101.15%-63.65%100.82%
EBT Per EBIT
96.11%96.11%134.69%10.21%124.59%
Return on Assets (ROA)
5.28%5.28%-17.53%0.71%-14.09%
Return on Equity (ROE)
10.27%9.76%-38.29%1.29%-24.83%
Return on Capital Employed (ROCE)
11.26%11.26%-18.50%-14.59%-15.01%
Return on Invested Capital (ROIC)
6.49%6.49%-15.45%8.60%-13.18%
Return on Tangible Assets
5.67%5.67%-21.04%0.88%-14.97%
Earnings Yield
6.79%4.55%-27.78%0.49%-13.66%
Efficiency Ratios
Receivables Turnover
 7.52 7.52 5.68 4.40 5.34
Payables Turnover
 12.92 12.92 6.19 5.08 7.40
Inventory Turnover
 1.64 1.64 1.27 0.97 1.49
Fixed Asset Turnover
 14.26 14.26 10.70 8.94 8.09
Asset Turnover
 1.42 1.42 1.25 0.99 0.96
Working Capital Turnover Ratio
 2.92 3.07 2.92 2.40 1.72
Cash Conversion Cycle
 242.72 242.72 292.87 386.71 263.26
Days of Sales Outstanding
 48.52 48.52 64.31 82.88 68.34
Days of Inventory Outstanding
 222.46 222.46 287.48 375.68 244.23
Days of Payables Outstanding
 28.26 28.26 58.92 71.85 49.31
Operating Cycle
 270.98 270.98 351.79 458.56 312.57
Cash Flow Ratios
Operating Cash Flow Per Share
 0.09 0.09 -0.09 -0.08 -0.06
Free Cash Flow Per Share
 0.07 0.07 -0.12 -0.09 -0.08
CapEx Per Share
 0.02 0.02 0.03 0.01 0.02
Free Cash Flow to Operating Cash Flow
 0.81 0.81 1.35 1.15 1.33
Dividend Paid and CapEx Coverage Ratio
 5.27 5.27 -2.89 -6.54 -3.03
Capital Expenditure Coverage Ratio
 5.27 5.27 -2.89 -6.54 -3.03
Operating Cash Flow Coverage Ratio
 0.44 0.44 -0.34 -0.40 -0.31
Operating Cash Flow to Sales Ratio
 0.09 0.09 -0.10 -0.10 -0.09
Free Cash Flow Yield
13.85%9.29%-27.04%-8.15%-11.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.74 22.00 -3.60 203.90 -7.32
Price-to-Sales (P/S) Ratio
 0.55 0.82 0.50 1.47 1.07
Price-to-Book (P/B) Ratio
 1.44 2.15 1.38 2.62 1.82
Price-to-Free Cash Flow (P/FCF) Ratio
 7.22 10.76 -3.70 -12.27 -8.74
Price-to-Operating Cash Flow Ratio
 5.84 8.72 -4.98 -14.14 -11.63
Price-to-Earnings Growth (PEG) Ratio
 0.01 -0.16 <0.01 -1.92 -0.12
Price-to-Fair Value
 1.44 2.15 1.38 2.62 1.82
Enterprise Value Multiple
 5.35 7.62 -11.19 30.03 -10.85
Enterprise Value
 85.07M 121.06M 88.16M 152.42M 58.87M
EV to EBITDA
 5.35 7.62 -11.19 30.03 -10.85
EV to Sales
 0.64 0.90 0.75 1.67 1.02
EV to Free Cash Flow
 8.37 11.91 -5.51 -13.89 -8.29
EV to Operating Cash Flow
 6.78 9.65 -7.41 -16.02 -11.02
Tangible Book Value Per Share
 0.32 0.32 0.20 0.29 0.33
Shareholders’ Equity Per Share
 0.36 0.37 0.32 0.43 0.36
Tax and Other Ratios
Effective Tax Rate
 0.29 0.29 -0.01 1.64 >-0.01
Revenue Per Share
 0.96 0.96 0.88 0.77 0.62
Net Income Per Share
 0.04 0.04 -0.12 <0.01 -0.09
Tax Burden
 0.71 0.71 1.01 -0.64 1.01
Interest Burden
 0.66 0.66 1.34 -0.55 1.25
Research & Development to Revenue
 0.02 0.02 0.02 0.01 0.02
SG&A to Revenue
 0.56 0.56 0.66 0.28 0.27
Stock-Based Compensation to Revenue
 0.02 0.02 0.04 0.03 0.04
Income Quality
 2.52 2.52 0.72 -14.42 0.63
Currency in USD